Investor insights
Sectors invested in
Funding rounds participated in
$20M sweet spot round size
Most of their 141 investments are in rounds between $11M and $38M
Investor type
Basic info
Industry
Sectors
Date founded
1987
Investments made
Xeltis raised $14M on August 14, 2023
Investors: Ysios Capital, DaVita Venture Group, VI Partners AG, Grand Patika and EQT Life Sciences
Evommune raised $50M on April 26, 2023
Investors: Arix Bioscience plc, Amplitude Ventures, Andera Partners, SymBiosis and EQT Life Sciences
QurAlis raised $88M on March 9, 2023
Investors: Sanofi Ventures, Life Sciences Partners (LSP), MP Healthcare Venture Management Inc, Mission Bay Capital, Mission BioCapital, Inkef and EQT Life Sciences
Xeltis raised $34M on February 21, 2023
Investors: DaVita Venture Group, Grand Pharmaceutical (China) Co., Ltd., Invest-NL and EQT Life Sciences
Undisclosed raised $39M on August 23, 2022
Investors: Grand Patika, FundPlus, Novalis LifeSciences LLC, Omega Funds and EQT Life Sciences
Imcheck Therapeutics raised $100M on June 13, 2022
Investors: Pureos Bioventures, Gimv, The Invus Group, Earlybird Venture Capital, Eurazeo, The Leukemia & Lymphoma Society, Wellington Partners and EQT Life Sciences
Ariceum Therapeutics raised $27M on June 8, 2022
Investors: Pureos Bioventures, HealthCap and EQT Life Sciences
Perfuze raised $26M on February 9, 2022
Investors: Seroba-Kernel Ltd (Ireland), EarlyBird Snacks, SV Life Sciences, Enterprise Ireland and EQT Life Sciences
ViCentra raised $74M on December 16, 2021
Investors: Inkef, Health Innovations, Partners in Equity and EQT Life Sciences
AviadoBio raised $78M on December 2, 2021
Investors: Monograph Capital, F-Prime Capital Partners, The Dementia Discovery Fund, Advent Life Sciences and EQT Life Sciences